Skip to content

Multicenter, prospective cohort study of clip band ligation anti-refux therapy (C-BLART) of elderly gastroesophageal reflux disease (GERD) with interstitial lung disease (ILD)

Multicenter, prospective cohort study of clip band ligation anti-refux therapy (C-BLART) of elderly gastroesophageal reflux disease (GERD) with interstitial lung disease (ILD)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300067795
Enrollment
Unknown
Registered
2023-01-28
Start date
2023-01-17
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastroesophageal reflux disease(GERD)with interstitial lung disease(ILD)

Interventions

elderly gastroesophageal reflux disease (GERD) with interstitial lung disease (ILD):C-BLART (clip band ligation anti-refux therapy)
elderly gastroesophageal reflux disease (GERD) with interstitial lung disease (ILD):Drug therapy as a control
elderly gastroesophageal reflux disease (GERD):C-BLART (clip band ligation anti-refux therapy)
elderly gastroesophageal reflux disease (GERD):Drug therapy as a control

Sponsors

The First Medical Center of PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >= 60 years old; 2. Meet the diagnostic criteria of GERD in 2020 "Chinese Expert Consensus Opinion on Gastroesophageal Reflux Disease"; 3. Meet the diagnostic criteria proposed by the American Thoracic Society (ATS) and the European Respiratory Society (ERS) for ILD in 2013; 4. Obtain informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with interstitial lung disease caused by other causes; 2. Patients with other diseases of the esophagus and lungs; 3. Patients who have undergone surgical lung biopsy or esophageal and gastric surgery; 4. Patients with end-stage heart, liver and kidney disease and other diseases that affect survival; 5. Patients who cannot tolerate endoscopic cardia coarctation; 6. Patients who have not obtained informed consent.

Design outcomes

Primary

MeasureTime frame
Treatment success rate;DeMeester score;Number of long reflux episodes;Total number of reflux episodes;pH measurements: Total % time pH<4;LES residual pressure;pulmonary function;

Secondary

MeasureTime frame
LES resting pressure;FEV1/FVC;arterial partial pressure of oxygen;

Countries

China

Contacts

Public ContactLinghu Enqiang

The First Medical Center of PLA General Hospital

linghuenqiang@vip.sina.com+86 135 0123 3558

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026